Dickkopf-3: An Update on a Potential Regulator of the Tumor Microenvironment

Area of Science:

• Oncology
• Molecular Biology
• Cell Biology

Background:

• Dickkopf-3 (Dkk-3) is a secreted antagonist of the Wingless-related integration site (Wnt) signaling pathway.
• Dkk-3's function in the tumor microenvironment is complex and context-dependent, with roles in both tumor promotion and suppression.
• The precise receptors and downstream effectors of Dkk-3 remain largely uncharacterized, obscuring its mechanism of action.

Purpose of the Study:

• To review the diverse functions of Dickkopf-3 (Dkk-3) within the tumor microenvironment.
• To explore the cell types expressing Dkk-3 in tumors, including fibroblasts, endothelial cells, immune cells, and epithelial cells.
• To discuss the potential therapeutic strategies involving Dkk-3 modulation for cancer treatment.

Main Methods:

• Literature review and synthesis of existing research on Dickkopf-3 (Dkk-3).
• Comparative analysis of Dkk-3 expression and function across different cancer types and cellular contexts.
• Discussion of potential therapeutic targeting of Dkk-3 pathways.

Main Results:

• Dickkopf-3 (Dkk-3) is expressed by various cells within the tumor microenvironment.
• Endogenous Dkk-3 exhibits context-dependent roles, potentially promoting or suppressing tumor growth.
• Dkk-3-based gene therapies show anti-tumorigenic effects, contrasting with the variable roles of endogenous Dkk-3.

Conclusions:

• Dickkopf-3 (Dkk-3) is a multifaceted protein with significant implications in cancer biology.
• Understanding Dkk-3's complex roles and mechanisms is crucial for developing effective cancer therapies.
• Targeting Dkk-3 activation or inhibition presents a promising avenue for novel cancer treatments, contingent on tumor type and specific context.